Kapadwala, Imtiyaz
Kapadwala, Imtiyaz was paid $749K by Medicaid between Jan 2018 and Dec 2024, across 22 billing codes. Its largest line is 99212, Office or other outpatient visit for the evaluation and management of an established patient, straightforward — 21% of everything it billed.
33Billing provider infoKAPADWALA, IMTIYAZ
BROOKLYN, NY 11237
BROOKLYN, NY 11237
33aNPI1912977364assigned 01/26/2006
33bProvider typeFoot Surgery Podiatrist
28Total paid$749K
24GClaims24,828
24DCodes billed22
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Foot Surgery Podiatrist providers in New York
Rank by total paid#8 of 190
Median peer was paid$33K
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,754 | $93K | |
| 2019 | 3,788 | $92K | |
| 2020 | 3,565 | $101K | |
| 2021 | 3,747 | $119K | |
| 2022 | 3,923 | $132K | |
| 2023 | 4,401 | $137K | |
| 2024incomplete | 2,650 | $75K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 21% | 5,252 | 4,880 | $154K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 13% | 1,645 | 1,640 | $100K |
| 20550 | 12% | 2,439 | 1,251 | $88K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 11% | 1,006 | 1,005 | $81K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.7% | 1,439 | 1,396 | $72K |
| L3000 | Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each | 7.7% | 255 | 152 | $58K |
| L3020 | Foot, insert, removable, molded to patient model, longitudinal/ metatarsal support, each | 6.8% | 466 | 233 | $51K |
| L2275 | Addition to lower extremity, varus/valgus correction, plastic modification, padded/lined | 3.5% | 394 | 197 | $26K |
| L2820 | Addition to lower extremity orthosis, soft interface for molded plastic, below knee section | 3.5% | 492 | 246 | $26K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 2.4% | 2,880 | 1,977 | $18K |
| 11720 | 2.4% | 2,602 | 2,589 | $18K | |
| 29540 | 2.0% | 1,318 | 681 | $15K |
10 more codes
| 11721 | 1.9% | 1,132 | $14K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.0% | 526 | $8K |
| 99072 | <1% | 243 | $4K | |
| 11719 | <1% | 1,567 | $3K | |
| A5512 | For diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each | <1% | 173 | $3K |
| A5500 | For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe | <1% | 171 | $3K |
| 17110 | <1% | 37 | $2K | |
| G0127 | Trimming of dystrophic nails, any number | <1% | 661 | $2K |
| 11056 | <1% | 73 | $1K | |
| 11055 | <1% | 57 | $1K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.